Antirestenotic effects of a novel polymer-coated D-24851 eluting stent. Experimental data in a rabbit iliac artery model

CardioVascular and Interventional Radiology

Volumn 30, Issue 6, 2007, Pages 1192-1200

  Lysitsas, Dimitrios N ^a   Katsouras, Christos S ^a   Papakostas, John C ^a   Toumpoulis, Ioannis K ^a   Angelidis, Charalampos ^a   Bozidis, Petros ^a   Thomas, Christopher G ^a   Seferiadis, Konstantin ^a,b   Psychoyios, Nikolaos ^b   Frillingos, Stathis ^b   Pavlidis, Nikolaos ^b   Marinos, Euaggelos ^c   Khaldi, Lubna ^d   Sideris, Dimitris A ^a   Michalis, Lampros K ^a,e  

^a Michailideion Cardiology Center   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^e UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Apoptosis; D 24851; Neointima; Restenosis; Stent

Indexed keywords

AMIDE; D 24851; DIMETHOATE; GLUFOSFAMIDE; N (PYRIDIN 4 YL)[1 (4 CHLORBENZYL)INDOL 3 YL]GLYOXYLAMIDE; POLYGLACTIN; POLYMER; RAPAMYCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; GROWTH INHIBITION; ILIAC ARTERY; IMPLANTATION; INTIMA; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RESTENOSIS; WOUND HEALING;

ACETAMIDES; ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BALLOON DILATATION; BLOOD VESSEL PROSTHESIS IMPLANTATION; BLOTTING, WESTERN; COATED MATERIALS, BIOCOMPATIBLE; GRAFT OCCLUSION, VASCULAR; HYPERPLASIA; ILIAC ARTERY; INDOLES; MALE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, FLUORESCENCE; MODELS, ANIMAL; POLYMERS; PROSTHESIS DESIGN; RABBITS; RANDOM ALLOCATION; STAINLESS STEEL; STENTS; TUNICA INTIMA;

EID: 35848937994     PISSN: 01741551     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00270-007-9027-4     Document Type: Article

References (28)

1. Farb A, Sangiorgi G, Carter AJ, et al. (1999) Pathology of acute and chronic coronary stenting in humans. Circulation 99:44-52
2. Bennet MR (2003) In-stent stenosis: pathology and implications for the development of drug eluting stents. Heart 89:218-224
3. Drachman DE, Edelman ER, Seifert P, et al. (2000) Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. J Am Coll Cardiol 36:2325-2332
4. Suzuki T, Kopia G, Hayashi S, et al. (2001) Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 104:1188-1193
5. Hou D, Narciso H, Kamdar K, et al. (2005) Stent-based nitric oxide delivery reducing neointimal proliferation in a porcine carotid overstretch injury model. Cardiovasc Intervent Radiol 28(1):60-65
6. Morice MC, Serruys PW, Sousa JE, et al. (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773-1780
7. Grube E, Silber S, Hauptmann KE, et al. (2003) TAXUS-1: six-and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 107:38-42
8. Mosser DD, Caron AW, Bourget L, et al. (1997) Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol 17:5317-5327
9. Kwak HJ, Jun CD, Pae HO, et al. (1998) The role of inducible 70-kDa heat shock protein in cell cycle control, differentiation, and apoptotic cell death of the human myeloid leukemic HL-60 cells. Cell Immunol 187:1-12
10. Lee WC, Lin KY, Chen KD, et al. (1992) Induction of HSP70 is associated with vincristine resistance in heat-shocked 9L rat brain tumor cells. Br J Cancer 66:653-659
11. Ito H, Shimojo T, Fujisaki H, et al. (1999) Thermal pre-conditioning protects rat cardiac muscle cells from doxorubicin-induced apoptosis. Life Sci 64:755-761
12. Bacher G, Nickel B, Emig P, et al. (2001) D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicity. Cancer Res 61:392-399
13. Creel CJ, Lovich MA, Edelman ER (2000) Arterial paclitaxel distribution and deposition. Circ Res 86:879-884
14. Raman VK, Edelman ER (1998) Coated stents: local pharmacology. Semin Intervent Cardiol 3:133-137
15. Cao W, Mohacsi P, Shorthouse R, et al. (1995) Effects of rapamycin on growth factor-stimulated vascular smooth muscle cell DNA synthesis. Inhibition of basic fibroblast growth factor and platelet-derived growth factor action and antagonism of rapamycin by FK506. Transplantation 59:390-395
16. Morris RE (1992) Rapamycins: antifungal, antitumor, antiproliferative, and immunosuppressive macrolides. Transplant Rev 6:39-87
17. Seker H, Bertram B, Burkle A, et al. (2000) Mechanistic aspects of the cytotoxic activity of glufosfamide, a new tumour therapeutic agent. Br J Cancer 82:629-634
18. Schwartz RS, Huber KC, Murphy JG, et al. (1992) Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 19:267-274
19. Kornowski R, Hong MK, Tio FO, et al. (1998) In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 31:224 -230
20. Guzman LA, Labhasetwar V, Song C, et al. (1996) Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplasty. Circulation 94:1441-1448
21. Whitley D, Goldberg SP, Jordan WD (1999) Heat shock proteins: a review of the molecular chaperones. J Vasc Surg 29:748-751
22. Helmbrecht K, Zeise E, Rensing L (2000) Chaperones in cell cycle regulation and mitogenic signal transduction: a review. Cell Prolif 33:341-365
23. Kirby LB, Mondy JS, Brophy CM (1999) Balloon angioplasty induces heat shock protein 70 in human blood vessels. Ann Vasc Surg 13:475-479
24. Gehrmann M, Pfister K, Hutzler P, et al. (2002) Effects of antineoplastic agents on cytoplasmic and membrane-bound heat shock protein 70 (Hsp70) levels. Biol Chem 383:1715-1725
25. Ito H, Kanzawa T, Kondo S, et al. (2005) Microtubule inhibitor D-24851 induces p53-independent apoptotic cell death in malignant glioma cells through Bcl-2 phosphorylation and Bax translocation. Int J Oncol 26(3):589-596
26. Scott S, O'Sullivan M, Hafizi S, et al. (2002) Human vascular smooth muscle cells from restenosis or in-stent stenosis sites demonstrate enhanced responses to p53: implications for brachytherapy and drug treatment for restenosis. Circ Res 90(4):398-404
27. Heldman AW, Cheng L, Jenkins GM, et al. (2001) Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation 103:2289-2295
28. Farb A, Heller PF, Shroff S, et al. (2001) Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 104:473-447